Rain Oncology Inc. General and Administrative Expense
Rain Oncology Inc. reported General and Administrative Expense of $4.11 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2023-11-09
- Rain Oncology Inc. general and administrative expense for the quarter ending 2023-09-30 was $4.11M, a 5.43% increase year-over-year.
- Rain Oncology Inc. general and administrative expense for the quarter ending 2023-06-30 was $5.41M, a 56.43% increase year-over-year.
- Rain Oncology Inc. general and administrative expense for the quarter ending 2023-03-31 was $5.07M, a 30.06% increase year-over-year.
- Rain Oncology Inc. general and administrative expense for the quarter ending 2022-12-31 was $4.48M, a 31.54% increase year-over-year.
- Rain Oncology Inc. general and administrative expense for fiscal 2022 was $15.74M, a 46.53% increase from fiscal 2021.
- Rain Oncology Inc. general and administrative expense for fiscal 2021 was $10.74M, a 199.05% increase from fiscal 2020.
- Rain Oncology Inc. general and administrative expense for fiscal 2020 was $3.59M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $4.11M 10-Q · filed 2023-11-09 | $9.53M derived: sum of 2 quarters · filed 2023-11-09 | $14.59M 10-Q · filed 2023-11-09 | $19.07M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $5.41M 10-Q · filed 2023-08-10 | $10.48M 10-Q · filed 2023-08-10 | $14.96M derived: sum of 3 quarters · filed 2023-08-10 | $18.86M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $5.07M 10-Q · filed 2023-05-11 | $9.54M derived: sum of 2 quarters · filed 2023-05-11 | $13.45M derived: sum of 3 quarters · filed 2023-11-09 | $16.91M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.38M derived: sum of 2 quarters · filed 2023-11-09 | $11.84M derived: sum of 3 quarters · filed 2023-11-09 | $15.74M 10-K · filed 2023-03-09 |
| 2022-09-30 | $3.90M 10-Q · filed 2023-11-09 | $7.36M derived: sum of 2 quarters · filed 2023-11-09 | $11.26M 10-Q · filed 2023-11-09 | $14.66M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $3.46M 10-Q · filed 2023-08-10 | $7.36M 10-Q · filed 2023-08-10 | $10.76M derived: sum of 3 quarters · filed 2023-08-10 | $13.91M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $3.90M 10-Q · filed 2023-05-11 | $7.30M derived: sum of 2 quarters · filed 2023-05-11 | $10.45M derived: sum of 3 quarters · filed 2023-05-11 | $13.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $6.56M derived: sum of 2 quarters · filed 2023-03-09 | $9.26M derived: sum of 3 quarters · filed 2023-03-09 | $10.74M 10-K · filed 2023-03-09 |
| 2021-09-30 | $3.15M 10-Q · filed 2022-11-10 | $5.85M derived: sum of 2 quarters · filed 2022-11-10 | $7.33M 10-Q · filed 2022-11-10 | $8.61M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.70M 10-Q · filed 2022-08-04 | $4.18M 10-Q · filed 2022-08-04 | $5.46M derived: sum of 3 quarters · filed 2022-08-04 | $6.05M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.48M 10-Q · filed 2022-05-04 | $2.76M derived: sum of 2 quarters · filed 2022-05-04 | $3.35M derived: sum of 3 quarters · filed 2022-05-04 | $4.47M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.87M derived: sum of 2 quarters · filed 2022-03-03 | $2.99M derived: sum of 3 quarters · filed 2022-03-03 | $3.59M 10-K · filed 2022-03-03 |
| 2020-09-30 | $591.00K 10-Q · filed 2021-11-10 | $1.71M derived: sum of 2 quarters · filed 2021-11-10 | $2.31M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.12M 10-Q · filed 2021-08-10 | $1.79M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $668.00K 10-Q · filed 2021-05-25 |